NRC Health amends exec stock awards, eliminates repurchase right; expects $9.4M Q2 expense

NRC HEALTH

Committee amended grants to CEO Trent Green (500k shares), COO Helen Hrdy (100k), and Chief Corp Dev Officer Andrew Monich (100k) to eliminate repurchase right.
Cash bonuses approved: ~$1.9M for Green, ~$0.5M each for Hrdy and Monich to cover estimated taxes from award changes.
Expected Q2 2026 expense of $9.4M: ~$6.5M non-cash accelerated equity comp and ~$2.9M cash bonus expense.
Effective tax rate impacted by non-deductibility of amounts; future period charges eliminated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.